2024 annual financial data
ABVC BioPharma 2024 Revenue growth
Direct answer
Revenue growth was 234.31%.
Operating income was -4,705,242 USD and net income was -4,902,878 USD.
Operating cash flow was -1,809,145 USD.
Get free ABVC BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 509,589 USD
- Operating income
- -4,705,242 USD
- Net income
- -4,902,878 USD
- Operating cash flow
- -1,809,145 USD